Siamak N. Nabili, MD, MPH
Dr. Nabili received his undergraduate degree from the University of California, San Diego (UCSD), majoring in chemistry and biochemistry. He then completed his graduate degree at the University of California, Los Angeles (UCLA). His graduate training included a specialized fellowship in public health where his research focused on environmental health and health-care delivery and management.
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
In this Article
- Erythropoietin (EPO) facts
- What is erythropoietin (EPO)?
- Chemically, what is erythropoietin (EPO)?
- What exactly does erythropoietin (EPO) do?
- Is the kidney the sole source of erythropoietin (EPO)?
- Why is an erythropoietin (EPO) test performed?
- How is the erythropoietin (EPO) test performed?
- What are normal erythropoietin (EPO) levels?
- What does an abnormal erythropoietin (EPO) level indicate?
- Can a person without a medical disease or condition have a high erythropoietin (EPO) level?
- Is erythropoietin (EPO) available as a prescribed medication?
- What are the clinical uses of erythropoietin (EPO)?
What are the clinical uses of erythropoietin (EPO)?
Erythropoietin [epoetin alfa (Epogen, Procrit)] is used in many clinical settings. The most common use is in people with anemia (low blood count) related to kidney dysfunction. When the kidneys are not properly functioning, they produce less than normal amounts of erythropoietin, which can lead to low red blood cell production, or anemia. Therefore, by replacing the erythropoietin with an injection of synthetic erythropoietin, anemia related to kidney disease may be treated. Currently, Epogen or Procrit is a standard part of therapy in patients with kidney disease who require dialysis to both treat and prevent anemia.
Other uses of erythropoietin may include treatment of anemia related to the medication AZT (used to treat AIDS) and anemia associated with cancer.
Rambod Rouhbakhsh, M.D., MBA, FAAFP; American Board of Family Medicine
"Chapter 6J: Erythropoietin"
Find out what women really need.